18 Oct 2022 --- A “trailblazing” Stanford University study has underlined the positive effects of Hofseth BioCare’s (HBC) nutraceutical ingredient ProGo for restoring and maintaining gut health. The “first-of-its-kind” study – published in the peer-reviewed journal Biomolecules by MDPI – was conducted through a collaboration between HBC and Stanford University School of Medicine, US. It aimed to further investigate the gastrointestinal (GI)-protective properties of the bioactive peptides contained in salmon-derived ProGo.
